XVM-36508-20930
4 vaccinations
11 coded responses
40 check-ins
10 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 640 / MO
- Registered
- 2021-02-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-03
Registered in v-safe
-
2021-02-03
Dose 1 — Pfizer-BioNTech
-
2021-02-03
Survey response — 0 day, dose 1MedDRA: Asthenia, Dizziness, Dysgeusia, Headache, Hypoaesthesia oral, Immediate post-injection reaction, Nausea — Feeling: Good · Site: Pain · NauseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-02-04
- 2021-02-05
-
2021-02-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-07
-
2021-02-08
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain — Feeling: Fair · HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-02-09
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair · Headache, Fatigue or tirednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-02-10
- 2021-02-17
-
2021-02-24
Dose 2 — Pfizer-BioNTech
-
2021-02-24
Survey response — 0 day, dose 2MedDRA: Depressed mood, Discomfort, Dyspnoea, Immature granulocyte count, Immediate post-injection reaction — Feeling: Fair · Site: Pain · Fatigue or tirednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-02-25
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-05
- 2021-03-10
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-04-07
-
2021-05-26
Survey response — 3 month, dose 2MedDRA: Cough, Illness, Nasopharyngitis, Pyrexia, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test negative, Sneezing — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-05-26
Report sent to call center — 3 month, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-08-04
Dose 3 — Pfizer-BioNTech
-
2021-08-25
Survey response — 6 month, dose 2MedDRA: Gastroenteritis viral — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2024-11 · check-in answers available
-
2021-08-25
Survey response — 21 day, dose 3MedDRA: Gastroenteritis viral — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2024-11 · check-in answers available
-
2021-09-01
Survey response — 28 day, dose 3MedDRA: Fatigue, Oropharyngeal pain, Rhinorrhoea — Feeling: FairMedDRA releases: 2021-09,2024-11 · check-in answers available
- 2021-09-08
- 2021-09-15
- 2021-11-03
- 2022-02-02
- 2022-04-27
- 2022-08-04
-
2022-09-14
Dose 4 — Pfizer-BioNTech
-
2022-09-20
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Fatigue or tiredness · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitAdult check-in
-
2022-09-20
Report sent to call center — days 1–6 daily, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-09-21
Survey response — 7 day, dose 4MedDRA: Cough, Joint swelling, Respiratory tract congestion — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
- 2022-09-21
- 2022-09-21
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
-
2022-12-14
Survey response — 3 month, dose 4MedDRA: Pneumonia, Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11 · check-in answers available
-
2022-12-14
Report sent to call center — 3 month, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-15
- 2022-12-15
-
2023-03-15
Survey response — 6 month, dose 4MedDRA: Bronchitis, COVID-19 — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11 · check-in answers available
-
2023-03-15
Report sent to call center — 6 month, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-03-16
- 2023-03-16
- 2023-03-16
- 2023-03-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-03 | Pfizer-BioNTech | |
| 2 | 2021-02-24 | Pfizer-BioNTech | |
| 3 | 2021-08-04 | Pfizer-BioNTech | No |
| 4 | 2022-09-14 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-26 | Unsuccessful | |
| 2022-09-20 | Unsuccessful | Reported to VAERS voluntarily prior to GDIT contact |
| 2022-12-14 | Unsuccessful | Reported to VAERS voluntarily prior to GDIT contact |
| 2023-03-15 | Unsuccessful | Reported to VAERS voluntarily prior to GDIT contact |
Free text
Release 3
Systemic reaction (other): I had an adverse reaction 5 minutes after receiving the vaccine. First, my lips and tip of my tongue became numb, followed by a metallic taste. Then, I became pale, dizzy, nauseous, and felt like I was going to pass out. BP was 140/90. After the dizziness reduced, I got a bad headache, which lasted about 20 min. I still felt weak for about an hour.
Systemic reaction (other): Sore throat
Systemic reaction (other): Sore throat, congestion
Release 4
Systemic reaction (other): About 10 min after my shot, it was harder to breathe. I felt weighed down all over my body. Like I was being pulled down. It was hard to take a breath. This passed after about 15 min.
Release 8
Symptoms: We had colds. We tested negative for Covid-19. I was sick for three weeks with cough, sneezing, runny nose, fever and chest congestion. I took oral steroids. We have all recovered.
Release 9
Symptoms: Stomach flu currently. Obtained Pfizer booster 08/04/2021.
Symptoms: Stomach flu currently
Symptoms: Sore throat, runny nose, tired.
Release 12
Systemic reaction (other): Cough, congestion, swollen knee
Symptoms: Pneumonia from RSV obtained from my children
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Gastroenteritis viral | ✓ | · | ✓ |
| SD | Illness | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
| SRO | Asthenia | ✓ | ✓ | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Depressed mood | ○ | ✓ | ○ |
| SRO | Discomfort | ✓ | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Hypoaesthesia oral | ✓ | ✓ | ✓ |
| SRO | Immature granulocyte count | ○ | ✓ | ○ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Joint swelling | · | · | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release